Biochecker, you are right about his background. Also, he does everything himself and seems to think he is brilliant. Maybe he is surrounded with too many slimeballs and nobody provides critical feedback. In the whole company there is nobody with medical-commercial-market access or launch experience. His slide about 'exploring commercial activities' is full of BS as well as claims about having a transformative precision medicine. He needs to bring in people who have launched a drug before, know what to do at this stage, how to present the case and can focus on things that really matter.
Market Data 
Markets 
AI
